Julian A. Symons

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ALGS

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Aligos Therapeutics, Inc. (ALGS)	D.Phil. Executive Vice President, Chief Scientific Officer	$492,758	—	—	$384,545	$189,219	$12,000	$1,078,522
2024	Aligos Therapeutics, Inc. (ALGS)	D.Phil. Executive Vice President, Chief Scientific Officer	$487,879	—	—	$157,050	$177,588	$12,000	$834,517
2023	Aligos Therapeutics, Inc. (ALGS)	D.Phil. Executive Vice President, Chief Scientific Officer	$473,669	—	—	$100,804	$215,993	$45,853	$836,319
2022	Aligos Therapeutics, Inc. (ALGS)	D.Phil. Executive Vice President, Chief Scientific Officer	$455,451	—	—	$328,189	$151,210	$12,000	$946,850
2021	Aligos Therapeutics, Inc. (ALGS)	D.Phil., Executive Vice President, Chief Scientific Officer	$435,839	—	—	—	$165,549	$17,434	$618,822
2020	Aligos Therapeutics, Inc. (ALGS)	D.Phil. Executive Vice President, Chief Scientific Officer	$336,675	—	—	$2,248,233	$210,550	$32,885	$2,828,343

No earnings-call appearances or filed executive changes recorded yet.